US Stock MarketDetailed Quotes

SNSE Sensei Biotherapeutics

Watchlist

0.992
-0.006-0.60%

Close Apr 24 16:00 ET

24.86MMarket Cap-812P/E (TTM)

Sensei Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-26.15%37.06M

-37.60%8.14M

-44.50%7.74M

-4.99%10.18M

-11.84%11.01M

33.90%50.19M

38.62%13.05M

35.14%13.94M

9.48%10.71M

56.69%12.49M

Selling and administrative expenses

-5.25%18.77M

-36.02%3.65M

-17.51%3.92M

24.87%5.39M

15.34%5.8M

25.19%19.81M

64.97%5.7M

22.67%4.75M

11.14%4.32M

9.30%5.03M

-General and administrative expense

-5.25%18.77M

-36.02%3.65M

-17.51%3.92M

24.87%5.39M

15.34%5.8M

25.19%19.81M

64.97%5.7M

22.67%4.75M

11.14%4.32M

9.30%5.03M

Research and development costs

-39.77%18.3M

-38.83%4.49M

-58.45%3.82M

-25.17%4.78M

-30.19%5.2M

40.26%30.38M

23.32%7.35M

42.64%9.19M

8.39%6.39M

121.55%7.46M

Operating profit

26.15%-37.06M

37.60%-8.14M

44.50%-7.74M

4.99%-10.18M

11.84%-11.01M

-33.90%-50.19M

-38.62%-13.05M

-35.14%-13.94M

-9.48%-10.71M

-56.69%-12.49M

Net non-operating interest income expense

122.51%3.48M

-2.45%795K

67.13%844K

416.38%914K

1,283.58%927K

1,103.08%1.56M

2,810.71%815K

689.06%505K

331.71%177K

2,333.33%67K

Non-operating interest income

103.25%3.62M

35.63%826K

70.29%877K

172.78%952K

212.58%969K

122.88%1.78M

82.34%609K

85.25%515K

85.64%349K

--310K

Non-operating interest expense

-34.25%144K

115.05%31K

230.00%33K

-77.91%38K

-82.72%42K

-67.31%219K

-167.32%-206K

-95.33%10K

17.01%172K

8,000.00%243K

Other net income (expense)

-1,536.11%-517K

-6,800.00%-67K

-1,255.00%-231K

-123K

-740.00%-96K

-93.55%36K

-94.74%1K

-96.47%20K

15K

Special income (charges)

---302K

--0

---6K

---191K

---105K

--0

-Gain on sale of property,plant,equipment

---302K

--0

---6K

---191K

---105K

--0

Other non- operating income (expenses)

-697.22%-215K

-6,800.00%-67K

-1,225.00%-225K

--68K

-40.00%9K

500.00%36K

-94.74%1K

--20K

----

--15K

Income before tax

29.82%-34.1M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-32.05%-48.59M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.41M

Income tax

Net income

29.82%-34.1M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-32.05%-48.59M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.41M

Net income continuous Operations

29.82%-34.1M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-32.05%-48.59M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.41M

Minority interest income

Net income attributable to the parent company

29.82%-34.1M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-32.05%-48.59M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.41M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

29.82%-34.1M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-32.05%-48.59M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.41M

Basic earnings per share

22.78%-1.22

25.00%-0.3

36.36%-0.28

8.82%-0.31

17.50%-0.33

-18.80%-1.58

-33.33%-0.4

-37.50%-0.44

-6.25%-0.34

4.76%-0.4

Diluted earnings per share

22.78%-1.22

25.00%-0.3

36.36%-0.28

8.82%-0.31

17.50%-0.33

-18.80%-1.58

-33.33%-0.4

-37.50%-0.44

-6.25%-0.34

4.76%-0.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-26.15%37.06M	-37.60%8.14M	-44.50%7.74M	-4.99%10.18M	-11.84%11.01M	33.90%50.19M	38.62%13.05M	35.14%13.94M	9.48%10.71M	56.69%12.49M
Selling and administrative expenses	-5.25%18.77M	-36.02%3.65M	-17.51%3.92M	24.87%5.39M	15.34%5.8M	25.19%19.81M	64.97%5.7M	22.67%4.75M	11.14%4.32M	9.30%5.03M
-General and administrative expense	-5.25%18.77M	-36.02%3.65M	-17.51%3.92M	24.87%5.39M	15.34%5.8M	25.19%19.81M	64.97%5.7M	22.67%4.75M	11.14%4.32M	9.30%5.03M
Research and development costs	-39.77%18.3M	-38.83%4.49M	-58.45%3.82M	-25.17%4.78M	-30.19%5.2M	40.26%30.38M	23.32%7.35M	42.64%9.19M	8.39%6.39M	121.55%7.46M
Operating profit	26.15%-37.06M	37.60%-8.14M	44.50%-7.74M	4.99%-10.18M	11.84%-11.01M	-33.90%-50.19M	-38.62%-13.05M	-35.14%-13.94M	-9.48%-10.71M	-56.69%-12.49M
Net non-operating interest income expense	122.51%3.48M	-2.45%795K	67.13%844K	416.38%914K	1,283.58%927K	1,103.08%1.56M	2,810.71%815K	689.06%505K	331.71%177K	2,333.33%67K
Non-operating interest income	103.25%3.62M	35.63%826K	70.29%877K	172.78%952K	212.58%969K	122.88%1.78M	82.34%609K	85.25%515K	85.64%349K	--310K
Non-operating interest expense	-34.25%144K	115.05%31K	230.00%33K	-77.91%38K	-82.72%42K	-67.31%219K	-167.32%-206K	-95.33%10K	17.01%172K	8,000.00%243K
Other net income (expense)	-1,536.11%-517K	-6,800.00%-67K	-1,255.00%-231K	-123K	-740.00%-96K	-93.55%36K	-94.74%1K	-96.47%20K		15K
Special income (charges)	---302K	--0	---6K	---191K	---105K	--0	--0	--0	--0	--0
-Gain on sale of property,plant,equipment	---302K	--0	---6K	---191K	---105K	--0	--0	--0	--0	--0
Other non- operating income (expenses)	-697.22%-215K	-6,800.00%-67K	-1,225.00%-225K	--68K	-40.00%9K	500.00%36K	-94.74%1K	--20K	----	--15K
Income before tax	29.82%-34.1M	39.39%-7.41M	46.90%-7.12M	10.91%-9.39M	17.96%-10.18M	-32.05%-48.59M	-30.60%-12.23M	-38.52%-13.42M	-7.82%-10.54M	-55.61%-12.41M
Income tax
Net income	29.82%-34.1M	39.39%-7.41M	46.90%-7.12M	10.91%-9.39M	17.96%-10.18M	-32.05%-48.59M	-30.60%-12.23M	-38.52%-13.42M	-7.82%-10.54M	-55.61%-12.41M
Net income continuous Operations	29.82%-34.1M	39.39%-7.41M	46.90%-7.12M	10.91%-9.39M	17.96%-10.18M	-32.05%-48.59M	-30.60%-12.23M	-38.52%-13.42M	-7.82%-10.54M	-55.61%-12.41M
Minority interest income
Net income attributable to the parent company	29.82%-34.1M	39.39%-7.41M	46.90%-7.12M	10.91%-9.39M	17.96%-10.18M	-32.05%-48.59M	-30.60%-12.23M	-38.52%-13.42M	-7.82%-10.54M	-55.61%-12.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	29.82%-34.1M	39.39%-7.41M	46.90%-7.12M	10.91%-9.39M	17.96%-10.18M	-32.05%-48.59M	-30.60%-12.23M	-38.52%-13.42M	-7.82%-10.54M	-55.61%-12.41M
Basic earnings per share	22.78%-1.22	25.00%-0.3	36.36%-0.28	8.82%-0.31	17.50%-0.33	-18.80%-1.58	-33.33%-0.4	-37.50%-0.44	-6.25%-0.34	4.76%-0.4
Diluted earnings per share	22.78%-1.22	25.00%-0.3	36.36%-0.28	8.82%-0.31	17.50%-0.33	-18.80%-1.58	-33.33%-0.4	-37.50%-0.44	-6.25%-0.34	4.76%-0.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall